white house glp-1 Patients eligible for weight loss drugs will be able to get at $50 a month: White House launches discount drug

Mechanism: Berberine activates the AMPK metabolic master pathway, improves insulin sensitivity, suppresses hepatic glucose production, and promotes fatty acid oxidation

The team also found that levels of use were similar across social grades, but that interest in using drugs to support weight loss in future was greater among more typically disadvantaged groups (among whom obesity is more prevalent), suggesting a demand not currently met by private prescriptions

Glucagon-like peptide-1 (GLP-1) receptor agonists are medications approved by the FDA for managing type 2 diabetes and, in some formulations, for chronic weight management

8 Quick service restaurants face the most direct pressure: in high-income zip codes with the highest GLP-1 adoption rates, QSR wallet share declined from 2.86% to 2.38% between 2022 and 2025

This increasing diabetic population drives the demand for insulin and GLP-1 receptor agonists in the region

So, it felt like one of the most important pieces of this formulation